Hindustan Aeronautics Limited (HAL) and Safran Helicopter Engines have signed a final contract through their joint venture SAFHAL Helicopter Engines to jointly design and develop the Aravalli helicopter engine. The 3,500–4,000 shp engine is intended for HAL’s planned 13‑tonne class multipurpose helicopter and its naval variant, marking an upgrade in India‑France defence cooperation.

Meta Platforms (META.O) turned lower after earlier gains of more than 3%.

The FDA has approved Revolution Medicines' pancreatic cancer drug Daraxonrasib, which will be marketed as Rasonque. The drug is the first therapy targeting one of the disease's key molecular pathogenic mechanisms. A late-stage trial published in May showed Daraxonrasib nearly doubled typical survival in an aggressive form of pancreatic cancer to 13.2 months versus 6.7 months with chemotherapy, the current standard of care.